# Fexofenadine in Patients With Active Rheumatoid Arthritis

> **NCT05264025** · PHASE1,PHASE2 · RECRUITING · sponsor: **October 6 University** · enrollment: 80 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Fexofenadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05264025
- **Lead sponsor:** October 6 University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264025, "Fexofenadine in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05264025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*